These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 8441555)
1. Prolonged clinical use of a heme oxygenase inhibitor: hematological evidence for an inducible but reversible iron-deficiency state. Kappas A; Drummond GS; Galbraith RA Pediatrics; 1993 Mar; 91(3):537-9. PubMed ID: 8441555 [TBL] [Abstract][Full Text] [Related]
2. Tin-mesoporphyrin inhibits heme oxygenase activity and heme-iron absorption in the intestine. Böni RE; Huch Böni RA; Galbraith RA; Drummond GS; Kappas A Pharmacology; 1993 Nov; 47(5):318-29. PubMed ID: 8265722 [TBL] [Abstract][Full Text] [Related]
3. Suppression of bilirubin production in the Crigler-Najjar type I syndrome: studies with the heme oxygenase inhibitor tin-mesoporphyrin. Galbraith RA; Drummond GS; Kappas A Pediatrics; 1992 Feb; 89(2):175-82. PubMed ID: 1734381 [TBL] [Abstract][Full Text] [Related]
5. Intestinal heme oxygenase inhibition and increased biliary iron excretion by metalloporphyrins. Drummond GS; Rosenberg DW; Kappas A Gastroenterology; 1992 Apr; 102(4 Pt 1):1170-5. PubMed ID: 1551526 [TBL] [Abstract][Full Text] [Related]
6. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Valaes T; Petmezaki S; Henschke C; Drummond GS; Kappas A Pediatrics; 1994 Jan; 93(1):1-11. PubMed ID: 8265301 [TBL] [Abstract][Full Text] [Related]
7. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Vreman HJ; Ekstrand BC; Stevenson DK Pediatr Res; 1993 Feb; 33(2):195-200. PubMed ID: 8433895 [TBL] [Abstract][Full Text] [Related]
8. Repression of hepatic delta-aminolevulinate synthase by heme and metalloporphyrins: relationship to inhibition of heme oxygenase. Cable EE; Cable JW; Bonkovsky HL Hepatology; 1993 Jul; 18(1):119-27. PubMed ID: 8325603 [TBL] [Abstract][Full Text] [Related]
9. Tin-protoporphyrin in the management of children with Crigler-Najjar disease. McDonagh AF Pediatrics; 1990 Jul; 86(1):151-2. PubMed ID: 2359679 [No Abstract] [Full Text] [Related]
10. Tissue distribution of zinc-mesoporphyrin in rats: relationship to inhibition of heme oxygenase. Russo SM; Pepe JA; Donohue S; Cable EE; Lambrecht RW; Bonkovsky HL J Pharmacol Exp Ther; 1995 Feb; 272(2):766-74. PubMed ID: 7853192 [TBL] [Abstract][Full Text] [Related]
11. Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant. Reddy P; Najundaswamy S; Mehta R; Petrova A; Hegyi T J Perinatol; 2003 Sep; 23(6):507-8. PubMed ID: 13679941 [TBL] [Abstract][Full Text] [Related]
12. Tin(Sn+4)-diiododeuteroporphyrin; an in vitro and in vivo inhibitor of heme oxygenase with substantially reduced photoactive properties. Drummond GS; Greenbaum NL; Kappas A J Pharmacol Exp Ther; 1991 Jun; 257(3):1109-13. PubMed ID: 2046022 [TBL] [Abstract][Full Text] [Related]
13. Effect of Tin-mesoporphyrin, an inhibitor of haem catabolism, on intestinal iron absorption. Laftah AH; Raja K; Simpson RJ; Peters TJ Br J Haematol; 2003 Jul; 122(2):298-304. PubMed ID: 12846900 [TBL] [Abstract][Full Text] [Related]
14. Tin-mesoporphyrin in the treatment of refractory hyperbilirubinemia due to Rh incompatibility. Maisels MJ; Yang H J Perinatol; 2012 Nov; 32(11):899-900. PubMed ID: 23128060 [TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of severe neonatal hyperbilirubinemia. Drummond GS; Kappas A Semin Perinatol; 2004 Oct; 28(5):365-8. PubMed ID: 15686268 [TBL] [Abstract][Full Text] [Related]
17. Heme oxygenase: the physiological role of one of its metabolites, carbon monoxide and interactions with zinc protoporphyrin, cobalt protoporphyrin and other metalloporphyrins. Marks GS Cell Mol Biol (Noisy-le-grand); 1994 Nov; 40(7):863-70. PubMed ID: 7849553 [TBL] [Abstract][Full Text] [Related]